Figure timeline
Uğur Şahin is a German medical researcher, entrepreneur, and businessman. He is the co-founder and CEO of BioNTech, which developed the world’s first mRNA-based vaccine against COVID-19. He also serves as chairman of the scientific management board of the Helmholtz Institute for Translational Oncology (HI-TRON), a Mainz-based cutting-edge biopharmaceutical research laboratory he co-founded in 2018…
Text from Wikipedia, available under CC BY-SA 4.0.
business · German oncologist and immunologist (born 1965) · oncologist · university teacher · entrepreneur · physician · chief executive officer · researcher · academic · immunologist · chairperson of the executive board · also Uğur Şahin, Ugur Sahin, Şahin
Born 19 September 1965 · Q2505089
57 published statements · 0 followers
See & hear
5 photos
Media from Wikimedia Commons, hotlinked at the source under its own licence — see each file for author and terms.
Live now
Pulling headlines from trusted outlets — this usually takes a few seconds
Checking the wires…
Feed scan
These are live links, not archived citations — they only join the timeline once a collect run verifies and archives them.
Live pulse
Most recent outstanding titles, awards, and quotes
cancer can be defeated in the future
76%WikipediaSource
“As soon as the vaccine has been permitted, I will be one of the first to do it. But first we have to make sure that the vaccine arrives with those people who need it urgently: especially the elderly, people with pre-existing conditions and medical staff.”
“cancer can be defeated in the future”
Text from Wikipedia, available under CC BY-SA 4.0.
dw: BionTech'te görev değişimi: Uğur Şahin'in halefi açıklandı
Hürriyet: Uğur Şahin ve Özlem Türeci BioNTech'ten ayrılıyor
Kadir: Uğur Şahin ve Özlem Türeci'den flaş BioNTech kararı
Kadir: Uğur Şahin kanser ilacı için tarih verdi
Haber7: Uğur Şahin, kanser ilacı için 2026'yı işaret etti
Dunya: Uğur Şahin ve Özlem Türeci'ye milyonlarca TL'lik dava şoku!
Türkiye Gazetesi: Uğur şahin Haberleri
Awarded University Teacher of the Year (2022).
Text from Wikipedia, available under CC BY-SA 4.0.
Awarded honorary doctor of the University of Antwerp (2022).
Text from Wikipedia, available under CC BY-SA 4.0.
Awarded Warren Alpert Foundation Prize (2022).
Text from Wikipedia, available under CC BY-SA 4.0.
Awarded Louis-Jeantet Prize for Medicine (2022).
Text from Wikipedia, available under CC BY-SA 4.0.
Awarded Paul Ehrlich and Ludwig Darmstaedter Prize (2022).
Text from Wikipedia, available under CC BY-SA 4.0.
haberler.com: Milyarderler liginde bir Türk: Uğur Şahin dünyanın en zengin 323. kişisi! 7,6 milyar dolar serveti var
Doğruluk Payı rated the claim “Uğur Şahin’in mRNA aşıları hakkında yayımlanmış bilimsel makalesi bulunmuyor.” Yanlış.
Shown as reported and rated by a fact checker, not as an established fact.
haberler.com: Uğur Şahin'den tedirginlik yaratan aşı sözleri: Gelecek yıl farklı bir formüle ihtiyacımız olacak
Doğruluk Payı rated the claim “Uğur Şahin ve Özlem Türeci tıp doktoru değil.” Yanlış.
Shown as reported and rated by a fact checker, not as an established fact.
Awarded honorary doctor of University of Cologne in Cologne City Hall (2021).
Text from Wikipedia, available under CC BY-SA 4.0.
Awarded Axel Springer Award (2021).
Text from Wikipedia, available under CC BY-SA 4.0.
Awarded Princess of Asturias Award for Technical and Scientific Research (2021).
Text from Wikipedia, available under CC BY-SA 4.0.
Awarded William B. Coley Award (2021).
Text from Wikipedia, available under CC BY-SA 4.0.
Awarded Knight Commander's Cross of the Order of Merit of the Federal Republic of Germany (2021).
Text from Wikipedia, available under CC BY-SA 4.0.
Doğruluk Payı rated the claim “BioNTech CEO’su Uğur Şahin COVID-19 aşısı olmadı.” Yanlış.
Shown as reported and rated by a fact checker, not as an established fact.
Published “Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months” in New England Journal of Medicine — cited 1,358 times.
Sahin was elected as a member of the European Molecular Biology Organization (EMBO)
Text from Wikipedia, available under CC BY-SA 4.0.
Alt News rated the claim “Childhood image of BioNTech co-foudner Uğur Şahin” False.
Shown as reported and rated by a fact checker, not as an established fact.
Doğruluk Payı rated the claim “Fotoğraftaki çocuğun Prof. Dr. Uğur Şahin olduğu iddiası” Yanlış.
Shown as reported and rated by a fact checker, not as an established fact.
Awarded Financial Times Person of the Year (2020).
Text from Wikipedia, available under CC BY-SA 4.0.
Published “Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine” in New England Journal of Medicine — cited 14,104 times.
Published “Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates” in New England Journal of Medicine — cited 2,390 times.
Published “Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults” in Nature — cited 1,350 times.
Awarded German Cancer Award (2019).
Text from Wikipedia, available under CC BY-SA 4.0.
Awarded Mustafa Prize (2019).
Text from Wikipedia, available under CC BY-SA 4.0.
Sahin was involved in establishing the new Helmholtz Institute HI-TRON, which is a cooperation between the German Cancer Research Center (DKFZ) and TRON
Text from Wikipedia, available under CC BY-SA 4.0.
After showing in a randomized clinical trial that this drug significantly boosted advanced gastric cancer patients' overall survival, the company was sold to Astellas Pharma for over €400 million
Text from Wikipedia, available under CC BY-SA 4.0.
Was among the founders of the Cluster of Individualized Immunointervention (CI3) in Mainz
Text from Wikipedia, available under CC BY-SA 4.0.
Published “Stable, Single-Layer MX<sub>2</sub> Transition-Metal Oxides and Dichalcogenides in a Honeycomb-Like Structure” in The Journal of Physical Chemistry C — cited 1,397 times.
Co-founded TRON (Translational Oncology at the University Medical Center of Johannes Gutenberg University Mainz)
Text from Wikipedia, available under CC BY-SA 4.0.
Published “Monolayer honeycomb structures of group-IV elements and III-V binary compounds: First-principles calculations” in Physical Review B — cited 2,092 times.
Published “Two- and One-Dimensional Honeycomb Structures of Silicon and Germanium” in Physical Review Letters — cited 3,153 times.
Career landmark: chief executive officer (2008).
Text from Wikipedia, available under CC BY-SA 4.0.
As part of the newly created biotechnology start-up offensive (GO-Bio)
Text from Wikipedia, available under CC BY-SA 4.0.
Career landmark: university teacher (2006).
Text from Wikipedia, available under CC BY-SA 4.0.
Awarded Georges Köhler Prize (2005).
Text from Wikipedia, available under CC BY-SA 4.0.
“Their first company, founded in 2001, was called Ganymed – not after the handsome hero of Greek myth but a Turkish expression roughly meaning “earned through hard work”
With his wife Özlem Türeci and his mentor Christoph Huber
Text from Wikipedia, available under CC BY-SA 4.0.
While maintaining his position at the University of Mainz, Şahin began to engage in entrepreneurial activities, co-founding two pharmaceutical companies, in 2001 and 2008, with his partner and spouse Özlem Türeci
Text from Wikipedia, available under CC BY-SA 4.0.
Şahin became head of the junior research group of SFB 432 (Sonderforschungsbereiche, Collaborative Research Centers) of the University Medical Center Mainz, and in 2003 chair of the Tumor Vaccine Center
Text from Wikipedia, available under CC BY-SA 4.0.
Joined Christoph Huber at the University Medical Center Mainz
Text from Wikipedia, available under CC BY-SA 4.0.
And became a professor of experimental oncology in 2006
Text from Wikipedia, available under CC BY-SA 4.0.
In the field of molecular medicine and immunology
Text from Wikipedia, available under CC BY-SA 4.0.
Studied at Saarland University (1992–1994).
Text from Wikipedia, available under CC BY-SA 4.0.
Studied at University of Cologne, doctorate (1984–1992).
Text from Wikipedia, available under CC BY-SA 4.0.
With a thesis on immunotherapy against tumor cells (bispecific monoclonal antibodies for the activation of cytostatic precursors on tumor cells), which was graded summa cum laude
Text from Wikipedia, available under CC BY-SA 4.0.
And was the first child at the school with Turkish guest worker parents
Text from Wikipedia, available under CC BY-SA 4.0.
Born 1965-09-19.
Text from Wikipedia, available under CC BY-SA 4.0.
Connections
Family we also track